Connection
Paul Toren to 2-Pyridinylmethylsulfinylbenzimidazoles
This is a "connection" page, showing publications Paul Toren has written about 2-Pyridinylmethylsulfinylbenzimidazoles.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.025 |
|
|
|
-
Ogilvie BW, Yerino P, Kazmi F, Buckley DB, Rostami-Hodjegan A, Paris BL, Toren P, Parkinson A. The proton pump inhibitor, omeprazole, but not lansoprazole or pantoprazole, is a metabolism-dependent inhibitor of CYP2C19: implications for coadministration with clopidogrel. Drug Metab Dispos. 2011 Nov; 39(11):2020-33.
Score: 0.025